No phaseSuspended
Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3 (LOPAIN3)
Clinical Investigation Plan First in Human Trial Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy "LOPAIN3"
- Sponsor
- Spinal Stabilization Technologies (Industry)
- Enrollment
- 50 planned
- Conditions
- Back Pain With Radiation; Radiculopathy; Back Pain; Disc Herniation; Herniated Nucleus Pulposus; Herniated Disc; Disc Injury; Disk Herniated Lumbar
- Interventions
- PerQdisc Nucleus Replacement System
- Ages
- adults, older adults
- Registry
- NCT05732818
Full record on ClinicalTrials.gov
From the registry
This study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a minimally invasive posterolateral (MIPL) approach. Patients that are at least 21 years or older, presenting with symptomatic radiculopathy from a focal lumbar disc herniation that requires surgical decompression will be included in this study.
Primary outcomes
- Safety: Number of Patients with Serious Adverse Events related to the PerQdisc
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered